The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

Study

Study ID	Alternative Stable ID	Type
EGAS00001005055		Other

Study Description

A surrogate marker based on the epigenome that captures these components in easily accessible epithelial tissue could potentially identify women at risk. The WID-BC-index identifies women with breast cancer based on a DNA methylation signature derived from cervical smear samples.

Study Datasets 6 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00001008144	SNP data for 313 loci required for calculation of the Breast cancer PRS SNP data for 313 loci required for calculation of the Breast cancer PRS		1055
EGAD00001008145	SNP data of 28 sites required for the Ovarian cancer PRS (controls) SNP data of 28 sites required for the Ovarian cancer PRS (controls)		749
EGAD00010002079	Raw methylation data from cervical samples in controls. Raw methylation data from cervical samples in controls.	Illumina MethylationEPIC Array	1094
EGAD00010002080	Raw methylation data from cervical samples in controls. Raw methylation data from cervical samples in controls.	Illumina MethylationEPIC Array	202
EGAD00010002081	Raw methylation data from cervical samples in individuals with breast cancer. Raw methylation data from cervical samples in individuals with breast cancer.	Illumina MethylationEPIC Array	442
EGAD00010002082	Raw methylation data from buccal samples in individuals with breast cancer. Raw methylation data from buccal samples in individuals with breast cancer.	Illumina MethylationEPIC Array	200

Who archives the data?

Publications

Citations

Retrieving...